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S100B is expressed in various types of glial cells and is involved in regulating many
aspects of their function. However, little is known about its role during nervous system
development. In this study, we investigated the effect of inhibiting the onset of S100B
synthesis in the development of the enteric nervous system, a network of neurons and
glia located in the wall of the gut that is vital for control of gastrointestinal function.
Intact gut explants were taken from embryonic day (E)13.5 mice, the day before the first
immunohistochemical detection of S100B, and cultured in the presence of arundic acid,
an inhibitor of S100B synthesis, for 48 h. The effects on Sox10-immunoreactive enteric
neural crest progenitors and Hu-immunoreactive enteric neurons were then analyzed.
Culture in arundic acid reduced the proportion of Sox10+ cells and decreased cell
proliferation. There was no change in the density of Hu+ enteric neurons, however,
a small population of cells exhibited atypical co-expression of both Sox10 and Hu,
which was not observed in control cultures. Addition of exogenous S100B to the
cultures did not change Sox10+ cell numbers. Overall, our data suggest that cell-
intrinsic intracellular S100B is important for maintaining Sox10 and proliferation of the
developing enteric glial lineage.
Keywords: enteric nervous system, enteric glia, S100B, Sox10, enteric nervous system development, glia
development
INTRODUCTION
The enteric nervous system (ENS) is a large, complex division of the autonomic nervous
system. Located within the wall of the gastrointestinal tract, the ENS is vital for the control
of gastrointestinal function, regulating motility, secretion, blood flow and many other activities
(Furness, 2006). Enteric glial cells are integral to the function of the ENS and the gut, playing roles
in various physiological and pathophysiological processes (Bush et al., 1998; Cornet et al., 2001;
Cirillo et al., 2011; Gulbransen and Sharkey, 2012; Neunlist et al., 2014; Coelho-Aguiar et al., 2015;
Kabouridis et al., 2015). Although several studies have examined the signaling pathways involved
in glial differentiation (Nishino et al., 2010; Chalazonitis et al., 2011; Ngan et al., 2011; Mundell
et al., 2012), little is currently known about what role enteric glia play during ENS development
(Kabouridis et al., 2015; Le Berre-Scoul et al., 2016).
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All the neurons and glia of the ENS arise from neural crest
cells that migrate into the gut during development (Yntema and
Hammond, 1954; Le Douarin and Teillet, 1973). These enteric
neural crest-derived cells (ENCCs) mostly arise from the caudal
hindbrain (“vagal”) level of the neural tube, entering the foregut
at embryonic day (E)9.5 in mice and colonizing the entire length
of the gut by E14.5 (Kapur et al., 1992). During migration, ENCCs
undergo extensive proliferation and begin to differentiate into
neurons and glia. At E10.5, a subpopulation (10–15%) of ENCCs
expresses pan-neuronal markers (Baetge and Gershon, 1989;
Young et al., 1999). Expression of the glial precursor marker,
brain fatty acid binding protein (BFABP; Kurtz et al., 1994),
can be found at E11.5 (Young et al., 2003), with expression
of the glial markers S100B and glial fibrillary acidic protein
(GFAP) identified at E14.5 and E16.5 respectively (Rothman
et al., 1986; Young et al., 2003). Sox10, another marker of enteric
glia in the mature ENS is initially found in all undifferentiated
ENCCs (Young et al., 2002, 2003). It is downregulated in enteric
neurons, but maintained in glial precursors and the majority
of mature enteric glia (Young et al., 2003; Laranjeira et al.,
2011; Boesmans et al., 2015b). During development, Sox10
expression is important for the maintenance of the neural crest
progenitor pool (Paratore et al., 2001; Kim et al., 2003). Mice
with homozygous mutations in Sox10 are embryonic lethal and
have a complete lack of ENCCs in their intestines, as well as other
neural crest defects (Southard-Smith et al., 1998). In addition,
Sox10 expression is important for peripheral glia development
(Britsch et al., 2001) and recently has been found to promote the
expression of S100B in Schwann cell precursors to induce their
differentiation (Fujiwara et al., 2014).
S100B is a member of the EF-family of Ca2+ binding proteins
expressed in a variety of cell types, including astrocytes and
enteric glia (Ferri et al., 1982; Hoff et al., 2008; Boesmans et al.,
2015b). Its function has been extensively studied in astrocytes of
the central nervous system (CNS) (Steiner et al., 2011; Donato
et al., 2013). S100B has several intracellular binding partners
(Santamaria-Kisiel et al., 2006), and in addition, is also secreted
from glial cells, acting on cell surface receptors, such RAGE
(receptor for advanced glycation end products) (Shashoua et al.,
1984; Hofmann et al., 1999). In the CNS, expression of S100B
by oligodendrocytes and astrocytes during development appears
to herald the end of their proliferative capability and marks
their differentiation status (Deloulme et al., 2004; Raponi et al.,
2007). However, its function in ENS development has not been
previously examined.
To explore the role of S100B in ENS development, we
used arundic acid (ONO-2506), an agent that has been
shown to inhibit S100B synthesis in astrocytes (Tateishi et al.,
2002). To prevent the onset of S100B expression, explants
of embryonic gut were taken from E13.5 mice, the day
before the first immunohistochemical detection of S100B, and
cultured in the presence of arundic acid for 48 h. Culture
in arundic acid eliminated the appearance of S100B+ glial
cells, and resulted in a decrease in the number of Sox10+
ENCCs, as well as reduced density and proliferation of ENCCs.
There was no effect on the density of enteric neurons that
express the RNA-binding protein, HuC/D (Hu), however, a
small population of ENCCs exhibited co-expression of both
Hu and Sox10. The mechanism of action of arundic acid
has not been published, but it is known to also influence
the expression of several other genes (Asano et al., 2005).
However, arundic acid did not affect Sox10 immunoreactivity
in adult cultures where S100B was already expressed. Our
results suggest that S100B may be important for enteric
glial differentiation by stimulating, or maintaining, Sox10
expression.
MATERIALS AND METHODS
Animals
Embryonic and postnatal gut tissue were collected from Wnt1-
CRE;R26R-GCaMP3 transgenic mice, where the reporter protein
GCaMP3 is expressed by all neural crest cell derivatives
(Boesmans et al., 2013). Wnt1-Cre;R26R-GCaMP3 mice were
bred by mating Wnt1-Cre mice (RRID:MGI:2386570; Danielian
et al., 1998) with R26R-GCaMP3 mice (RRID:IMSR_JAX:014538;
Zariwala et al., 2012). Midday of the day on which a plug was
found was designated E0.5. Pregnant mice were killed by cervical
dislocation; postnatal day (P)0 and embryonic mice were killed
by decapitation. This study was carried out in accordance with
European Directive 2010/63/EU and Belgian Royal Decree of 6
April 2010. The protocol was approved by the Animal Ethics
Committee of the University of Leuven (project #192/2013).
In vitro Organ Culture
E13.5 embryos were dissected in filter sterilized Krebs (containing
the following in mM: 120.9 NaCl, 5.9 KCl, 1.2 MgCl2, 1.2
NaH2PO4, 14.4 NaHCO3, 2.5 CaCl2, and 11.5 glucose). The
entire embryonic gut, including the stomach, small intestine
and colon, was removed and pinned in small Sylgard dishes
using 50 µm diameter tungsten wire, as described previously
(Shyer et al., 2013). Gut explants were cultured in 2 ml
of DMEM/F12 with 1% penicillin/streptomycin. Arundic acid
(ONO-2506, Tocris Bioscience, catalog #4530) was dissolved
in DMSO and added to the culture media. S100B (Sigma,
cat #A6677) was dissolved in Krebs or Dulbecco’s phosphate
buffered saline (DPBS) and also added to the culture media,
either alone, or in combination with arundic acid. Appropriate
vehicle control cultures were also performed. All preparations
were incubated for 48 h at 37◦C, 5% CO2 with media refreshed
at 24 h.
Adult ENS Cultures
Myenteric ENS cultures from adult mice were made as described
previously (Lowette et al., 2014). Briefly, the small intestine
was collected in sterile filtered Krebs, the outer longitudinal
muscle with myenteric plexus were removed and digested in a
mixture of collagenase type II (338 units/ml; Worthington
Biochemical Corporation, CLS-2), protease (10 mg/ml;
Sigma, P4693) and bovine serum albumin (4 mg/ml; Serva
Electrophoresis, 11930) in Hanks’ balanced salt solution for
15 min at 37◦C. The reaction was stopped by addition of Krebs
with 10% fetal bovine serum (FBS), cells were washed and
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resuspended in DMEM/F12 with 10% FBS, 1% glutamine,
0.5% penicillin/streptomycin and plated on 18 mm coverslips.
Cultures were allowed to grow for 24 h before addition
of the mouse culture media, containing DMEM/F12, 1%
glutamine, 0.5% penicillin/streptomycin, 0.25 µg/ml nerve
growth factor (Alomone Laboratories, N-130), with 0.2% N-2
supplement (Thermofisher Scientific, 17502048) and 0.2%
G-5 supplement (Thermofisher Scientific, 17503012). After
4–6 days in culture, culture medium containing either DMSO
(3 µl/ml) or arundic acid (300 µM) were added for 48 h,
with media changed after 24 h. Cells were then fixed for
immunohistochemistry.
Immunohistochemistry
All preparations were fixed in 4% formaldehyde (Sigma, 47629)
in 0.1 M PBS and processed for immunohistochemistry as
described previously (Boesmans et al., 2014). For preparations
of E13.5, E14.5 and E16.5 gut, the entire gut tube was dissected
for fixation. For P0, the gut was opened along the mesenteric
border and pinned on Sylgard dishes before fixation. The
entire mucosa and strips of circular muscle layers were then
removed. All preparations were washed in PBS, blocked for
2 h at room temperature in blocking solution (PBS with
0.5% Triton X-100 and 4% donkey serum), then incubated in
primary antibodies at 4◦C overnight. Primary antibodies were
diluted in blocking solution: rat anti-GFP (1:1000, Gentaur
04404-26); mouse anti-HuC/D (1:500, Molecular Probes
A21271; RRID:AB_221448); goat anti-Sox10 (1:300, Santa
Cruz Biotechnologies sc-17342; RRID:AB_2195374); rabbit
anti-S100B (1:500, Dako Z0311; RRID:AB_10013383); rabbit
anti-GFAP (1:500, Dako Z0334; RRID:AB_10013382); rabbit
anti-BFABP (1:250, Millipore, ABN14; RRID:AB_10000325).
After incubation in primary antisera, all samples were washed
in PBS, then incubated in secondary antibodies for 2 h
at room temperature (also diluted in blocking solution):
donkey anti-rat Alexa 488 (1:1000, Molecular Probes, A21208;
RRID:AB_141709); donkey anti-rabbit Alexa 488 (1:1000;
Molecular Probes, A12106); donkey anti-mouse Alexa 594
(1:1000; Molecular Probes, A21203; RRID:AB_141633); donkey
anti-sheep Alexa 647 (1:500, Molecular Probes, A21448;
RRID:AB_1500712).
Proliferation and Cell Death Assays
To examine proliferation, EdU (10 µM) was added to the culture
media for 6 h prior to fixation. Preparations were processed
for immunohistochemistry and then EdU incorporation detected
using a Click-iT EdU Alexa 647 kit (Invitrogen, C10340)
according to the manufacturer’s instructions. To examine cell
death, a Click-iT Plus TUNEL Assay with Alexa 647 (Molecular
Probes, C10619) was used according to the manufacturer’s
instructions.
Imaging and Analysis
After labeling, all preparations were imaged with either a Zeiss
LSM510 or LSM780 confocal laser scanning microscope (Cell
Imaging Core, KU Leuven). The ENCC network was visualized
using anti-GFP antisera to recognize the GCaMP3 molecule.
To examine differentiation, proliferation and cell death, single
optical section images were taken (3.1 µm depth for x25
magnification or 1.0 µm for x63 magnification images) in the
middle of the presumptive myenteric plexus. For embryonic gut
preparations and organ cultures, one field of view from each
region of the gut was imaged for analysis. For P0 gut, three
fields of view were examined from the myenteric plexus at each
gut region. For adult ENS cultures, two different fields of view
were examined for each coverslip. The numbers of GFP+, Hu+,
Sox10+ and S100B+ ENCCs were determined by visual counting
using ImageJ software (NIH). All images were blinded before
analysis. To examine the differences in the intensity of Sox10
immunohistochemistry, all preparations were imaged using the
same parameters. The fluorescent intensity of individual Sox10+
cells was calculated using Igor Pro (Wavemetrics, Lake Oswego,
OR, USA). Regions of interest (ROIs) were drawn over each cell
nucleus and the average fluorescent signal was calculated for each
ROI.
All population data, including graphs are presented as
mean ± SEM. Unless otherwise stated, n refers to the number of
gut preparations examined, with data collected from a minimum
of two different litters of mice. Statistical analyses were performed
with Prism (GraphPad software) or Microsoft Excel.
RESULTS
Development of Enteric Glial Cells
In order to investigate the role of enteric glia in ENS
development, we first characterized the proportion of ENCCs
expressing the glial marker, S100B, at various embryonic and
early postnatal ages. UsingWnt1-Cre;R26R-GCaMP3mice, where
all ENCCs express the reporter protein, GCaMP3, which can be
detected using anti-GFP antisera, we examined the proportion of
S100B+/GFP+ cells of the myenteric plexus in the duodenum
and colon at E13.5, E14.5, E16.5 and P0 mice. At E13.5, we
found no evidence of any S100B-immunoreactive cells in any
region of the gut (n = 4, data not shown). As previously
reported (Young et al., 2003), the earliest S100B-immunoreactive
cells were detected at E14.5, where they made up 13 ± 4%
(mean ± SEM, n = 4; Figure 1) of the total GFP+ ENCCs
in the duodenum. The proportion of S100B+/GFP+ cells
in the duodenum increased through development (Figure 1).
In the colon, very few S100B+ cells were present at E14.5.
A progressive increase in the proportion of S100B+/GFP+
cells was also observed in the colon from E14.5 to P0
(Figure 1D).
At E14.5 all S100B+ cells were also Sox10+. However, by
E16.5 and P0, a small proportion of S100B+ cells were not
immunoreactive for Sox10 (Figure 1B; 15 ± 3% for E16.5 and
6.7 ± 3% for P0 duodenum, n = 3 for both). In contrast, the
proportion of Sox10+/GFP+ ENCCs remains fairly similar in
the duodenum through late embryonic development and steadily
decreases in the colon (Figure 1E). As Sox10 is expressed by both
enteric glia as well as ENCC precursors, neuronal differentiation
through development most likely contributes to this progressive
decrease.
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FIGURE 1 | S100B and Sox10 expression in the developing ENS ofWnt1-CRE;R26R-GCaMP3 mice. Representative images of the myenteric plexus in the
duodenum at E14.5 (A), E16.5 (B), and P0 (C). A small number of S100B-immunoreactive ENCCs are present in the duodenum at E14.5, which are all Sox10+
(arrows). At E16.5, a small population of S100B+ cells are not immunoreactive for Sox10 (arrowheads). Scale bar = 20 µm for all. The proportions of
S100B+/GFP+ ENCCs (D) and Sox10+/GFP+ ENCCs (E) in the duodenum and colon at different ages. The proportion of S100B+ ENCCs increased during
development and in general, was higher in the duodenum than the colon at each age. The proportion of Sox10+ ENCCs in the duodenum remains similar between
E14.5 and P0, but decreases in the colon. Cell counts were made from n = 4 gut preparations for E14.5 (duodenum total of 914 GFP+ cells; colon 700), n = 3 for
E16.5 (duodenum 503 GFP+ cells; colon 517), and n = 3 for P0 (duodenum 1744 GFP+ cells; colon 2614).
We also observed BFABP+ glial precursors at E13.5
as described previously (data not shown; Young et al.,
2003), however, there was a large degree of variation in
the immunohistochemical staining, and we therefore could
not reliably quantify the proportion of BFABP+ ENCCs.
We were also unable to obtain reliable immunolabeling of
GFAP for cell counting at any embryonic age (data not
shown).
Inhibition of S100B Synthesis in
Embryonic Gut Cultures Using Arundic
Acid
To prevent S100B synthesis in the ENS, we cultured explants
of embryonic gut in arundic acid, which has been shown to
inhibit S100B synthesis in astrocytes (Asano et al., 2005; Cui
et al., 2012; Hanada et al., 2014). E13.5 gut was used, as this
was the day where no S100B-immunoreactive ENCCs were
present. Because arundic acid stock was dissolved in DMSO,
we also performed cultures in DMSO vehicle control (6 µl
DMSO in 2 ml culture media) as well as controls with culture
media only. In both control media only and DMSO vehicle
control cultures, S100B-immunoreactive cells were identified in
the duodenum after 48 h in culture (Figure 2). Arundic acid
(300 µM) inhibited the appearance of S100B immunoreactivity
in the ENS as no, or very few, S100B+ ENCCs could be
detected after 2 days culture in its presence (Figure 2). In the
caudal ileum, very little S100B expression was present in all
three culture conditions (Figure 2). This is most likely due to
the delay in glial differentiation along the rostral-caudal axis
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FIGURE 2 | Inhibition of S100B synthesis in the ENS using arundic
acid. E13.5 gut was cultured for 48 h in control media only, DMSO vehicle
control, and arundic acid. (A) Diagram of the gut showing the two regions
analyzed, the duodenum and ileum. (B) Representative images of
S100B-immunoreactive cells in the duodenum after culture. Many cells were
present in control and DSMO cultures. Very few S100B+ cells were present
after culture in arundic acid (arrow). Scale bar = 20 µm. (C) The number of
S100B+ cells per 10000 µm2 of gut area. In the duodenum, there was no
obvious difference in the density of S100B+ cells in control and DMSO
cultures. Almost no S100B+ cells were present in arundic acid cultures, which
was significantly reduced compared to both control groups. ∗p < 0.0001,
one-way ANOVA with Tukey post hoc test; numbers of gut preparations for
each condition are shown (total S100B+ cells counted: control 571 cells;
DMSO 276; arundic acid 32). In the ileum, very few S100B+ cells were
observed in any of the three culture conditions (control total 49 S100B+ cells;
DMSO 8; arundic acid 4). Inset shows the chemical structure of arundic acid.
of the gut. A lower concentration of arundic acid (150 µM)
was also examined, however, there were still abundant S100B+
ENCCs in the gut after 48 h culture in this condition (data not
shown).
The Effect of Arundic Acid on ENCC
Differentiation
To investigate the effect of blocking S100B synthesis on ENS
development, Hu and Sox10 expression were examined in
E13.5 gut explants after 2 days culture in control, DMSO and
arundic acid (300 µM). Two regions of the gut were analyzed,
the duodenum and ileum. After culture in control, DMSO or
arundic acid, there was no obvious difference in the density
of Hu+ enteric neurons in either the duodenum or ileum
(Figures 3A–A′′, one-way ANOVA, p > 0.05). The density
of Sox10+ ENCCs was significantly decreased after culture in
arundic acid in comparison to both control conditions in both
gut regions (Figures 3B–B′′, one-way ANOVA, p < 0.0001).
In addition, in the remainder of Sox10+ cells, the intensity
of Sox10 immunoreactivity appeared to be reduced in arundic
acid cultures (Figures 3B–B′′,C,C′). We therefore quantified the
fluorescence intensity of Sox10 immunoreactivity in individual
cells and found that the distribution profile differed for arundic
acid cultures compared to DMSO vehicle controls, with a
greater proportion of Sox10+ cells exhibiting lower fluorescence
intensity after culture in arundic acid (Figure 3D, two-way
ANOVA, p < 0.05). The cumulative frequency profile of Sox10
immunoreactivity was also significantly different for DMSO vs.
arundic acid cultures, making two distinct populations with
different Gaussian distribution fit parameters (Figure 3D, sum of
squares F-test, p< 0.0001).
To ensure the changes in Sox10 immunohistochemistry was
not due to a direct or S100B-independent effect of arundic acid,
we also applied arundic acid (300 µM) to adult ENS cultures,
where S100B+ enteric glia are already present. Arundic acid
should not affect existing S100B protein, but inhibit synthesis
of new protein (Asano et al., 2005). S100B-immunoreactive cells
were present after 48 h culture in both DMSO and arundic
acid (Figures 4A,B). Therefore, whilst the time-frame of S100B
turnover in the adult ENS is not known, it is likely to be
longer than the 48 h culture period used. There was no obvious
difference in the general appearance of cells between DMSO
and arundic acid cultures (Figures 4A,B). However, the overall
density of cells was difficult to examine as GFP+ ENS cells tended
to aggregate in clumps; hence, on each coverslip there where
dense ENS networks interspersed with large cell-free areas. The
immunofluorescence intensity of Sox10 in these S100B+ cells
was not significantly different in DMSO vs. arundic acid cultures
(Figures 4C,D,D′), indicating that arundic acid does not target
Sox10 independently of S100B.
Sox10 expression is maintained in glial cells but is
downregulated in neurons and generally does not co-localize
with neuronal markers (Young et al., 2002, 2003; Anderson et al.,
2006). However, in E13.5 gut cultured for 48 h in arundic acid,
we noticed a subpopulation of ENCCs that were immunoreactive
for both Hu and Sox10 (Figure 5). These were rarely observed
in control culture conditions, but were present in both the
duodenum and ileum of arundic acid cultures, although their
Sox10 immunoreactivity was weaker than other Sox10+, Hu-
negative ENCCs (Figure 5). During ENS development, a small
number of Sox10+ cells with weak, cytoplasmic, but not nuclear,
Hu immunoreactivity are present near the wavefront of ENCC
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FIGURE 3 | The effect of arundic acid on Hu+ and Sox10+ ENCCs in E13.5Wnt1-CRE;R26R-GCaMP3 gut cultured for 48 h. The duodenum and ileum
was examined for the proportion of Hu+/GFP+ ENCCs (A) and Sox10+/GFP+ ENCCs (B–D). Representative images of Hu+ and GFP+ ENCCs in the duodenum
of DMSO (A) and arundic acid (A′) cultures. (A′ ′) The density of Hu+ ENCCs did not differ for all three culture conditions in either gut region: p > 0.05, one-way
ANOVA. n-numbers of gut preparations are shown (total number of Hu+ cells: duodenum control 2364; DMSO 1536; arundic acid 2743; ileum control 2249 control;
DMSO 1187; arundic acid 1965). Representative images of Sox10+ and GFP+ ENCCs in the duodenum of DMSO (B) and arundic acid (B′) cultures. (B′ ′) The
density of Sox10+ ENCCs was significantly reduced in arundic acid cultures compared to both control and DMSO cultures in the duodenum and ileum:
∗p < 0.0001, one-way ANOVA with Tukey post hoc test. n-numbers are shown (total numbers of Sox10+ cells: duodenum control 2015; DMSO 1327; arundic acid
1010; ileum control 2050; DMSO 1090; arundic acid 1178). Scale bar = 20 µm for all. (C,C′) Higher magnification images of the insets from (B,B′) (boxes). The
majority of Sox10+ ENCCs in arundic acid cultures had lower levels of fluorescent immunolabeling (arrows) compared to controls, although some cells with “normal”
bright fluorescence were still present (arrowheads). Scale bar = 10 µm. (D) Frequency (left) and cumulative frequency (right) distributions of the fluorescent intensity
profile of sox10-immunoreactive ENCCs in the duodenum of DMSO (416 cells from n = 5 experiments) and arundic acid (180 cells from n = 5 experiments) cultures.
All preparations were imaged using the same parameters, the mean fluorescent intensity values of individual nuclei was calculated using Igor Pro and grouped in bins
of 25 arbitrary units (A.U.). The background intensity of the gut is approximately 25 A.U. The proportion of cells in each bin from each experiment was calculated.
A significantly greater proportion of cells had lower Sox10 immunofluorescence intensity (<100 A.U.) in arundic acid cultures compared to DMSO vehicle controls,
whilst a lower proportion had higher fluorescent intensity immunolabeling (∗p < 0.05, two-way ANOVA with Bonferroni post hoc test). The cumulative frequency
distribution was also different for the two populations (lines show cumulative Gaussian distribution fits).
migration as they colonize the gut (Young et al., 2004); however,
the cells in our arundic acid cultures appear to be different as
they have weak Sox10 immunoreactivity, and both cytoplasmic
as well as nuclear, albeit weak nuclear, Hu immunoreactivity
(Figure 5 arrows).
The Effect of Arundic Acid on ENCC
Proliferation, Density, and Cell Death
Maintenance of Sox10 expression is important for
neural crest survival and proliferation (Kapur, 1999;
Kim et al., 2003). We therefore examined whether the
reduced Sox10 immunoreactivity observed in our arundic
acid cultures influenced the appearance of the ENCC
network. The density of GFP+ ENCCs was significantly
reduced in E13.5 Wnt1-cre;R26R-GCaMP3 gut cultured in
arundic acid for 48 h in comparison to vehicle controls
(Figure 6A). We investigated whether this was due to a
change in proliferation or was caused by cell death. EdU
incorporation during the last 6 h of culture was used to
examine cell proliferation. The proportion of EdU+/GFP+
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FIGURE 4 | The effect of arundic acid on Sox10 immunoreactivity in adult glial cultures. Representative images from established mixed cultures of adult
myenteric ganglia where DMSO (A) or arundic acid (B) were added for 48 h. S100B+ glia were present in both culture conditions (arrowheads) as arundic acid does
not affect existing S100B protein. The majority of S100B+ glia had clear Sox10 immunoreactive nuclei (overlapping with DAPI; arrowheads). These were mixed ENS
cultures and GFP+ non-glial cells were also present. Scale bar = 50 µm for all. (C) Frequency (left) and cumulative frequency (right) distributions of the fluorescent
intensity profile of Sox10-immunoreactivity in DMSO (1459 cells from n = 10 coverslips from two different mice) and arundic acid (1332 cells from n = 10 coverslips
from two different mice) cultures. The distribution of both populations is not significantly different (p > 0.05, two-way ANOVA). (D,D′) Increased magnification of
Sox10-immunoreactive cells from (A,B) (boxes). The appearance of Sox10 immunofluorescence was similar between DMSO (D) and arundic acid (D′) cultures
(arrows).
FIGURE 5 | Co-localization of Hu and Sox10 in E13.5Wnt1-CRE;R26R-GCaMP3 gut after 48 h culture. Representative images of Hu+ and Sox10+ ENCCs
in DMSO (A) and arundic acid (B) cultures. Very few cells were found to be immunoreactive for both Hu and Sox10 in control and DMSO vehicle control cultures.
After culture in arundic acid, a subpopulation of ENCCs was found to be both Hu+ and Sox10+ (arrows), albeit the Sox10 immunoreactivity was generally not as
bright in these cells. Brighter Sox10+ cells that were not immunoreactive for Hu were also present (arrowheads). Scale bar = 20 µm. (C) The proportion of ENCCs
immunoreactive for both Hu and Sox10 was significantly greater in arundic acid cultures compared to control and DMSO cultures in the duodenum: ∗p < 0.0001,
one-way ANOVA, Tukey post hoc test, n-numbers are shown. There was no significant difference in the ileum (p > 0.05, one-way ANOVA).
ENCCs was significantly decreased in arundic acid cultures
compared to DMSO vehicle controls (Figures 6B,C,C′).
Co-localization of EdU with S100B was also examined
in DMSO vehicle control cultures to determine whether
S100B+ enteric glia are capable of continuing cell division,
and 22 ± 3% of S100B+ cells were found to be also
EdU+ (n = 5). As there were very few S100B+ cells
in arundic acid cultures (Figure 2, total of 32 S100B+
cells from the duodenum of 10 gut preparations), we did
not investigate their division in arundic acid. TUNEL
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FIGURE 6 | Effect of arundic acid on ENCC density and proliferation in
E13.5Wnt1-CRE;R26R-GCaMP3 gut after 48 h culture. (A) The density
of GFP+ ENCCs per 10000 µm2 was significantly reduced after culture in
arundic acid compared to DMSO vehicle controls in both the duodenum and
ileum: ∗p = 0.014 for duodenum, ∗p = 0.0099 for ileum, Student’s t-test,
n-numbers shown on graph (total GFP+ cells counted: duodenum DMSO
1561; arundic acid 2341; ileum DMSO 1339; arundic acid 1965). (B) The
proportion of EdU+/GFP+ ENCCS was significantly reduced in arundic acid
cultures: ∗p = 0.013 for duodenum, ∗p = 0.0025 for ileum, Student’s t-test,
n-numbers shown on graph. Represenative images of EdU incorporation in
GFP+ ENCCs in the duodenum of DMSO (C) and arundic acid (C′) cultures.
EdU+/GFP+ ENCCs were readily identifiable in DMSO cultures (arrows).
There were also many EdU+ non-ENCCs that were not immunoreactive for
GFP (arrowheads). In arundic acid cultures, there were fewer EdU+/GFP+
ENCCS, although EdU+/GFP-negative non-ENCCs were still present
(arrowheads). Scale bar = 20 µm.
staining was used to examine cell death. Only a small
proportion of GFP+ ENCCs exhibited TUNEL staining
in both DMSO and arundic acid cultures (Figure 7),
FIGURE 7 | Effect of arundic acid on ENCC cell death in E13.5
Wnt1-CRE;R26R-GCaMP3 gut after 48 h culture. Representative images
of TUNEL staining (arrows) in the duodenum after culture in DMSO (A) and
arundic acid (A′). Scale bar = 20 µm. (B) The proportion of TUNEL+/GFP+
ENCCs was not statistically different in the duodenum between arundic acid
and DMSO cultures (p > 0.05, Student’s t-test).
which was not significantly different (p > 0.05, Student’s
t-test).
Exogenous S100B Could Not Rescue the
Arundic Acid Induced Decrease in
Sox10+ ENCCs
To examine whether the change in Sox10+ ENCCs was
mediated by cell-intrinsic or paracrine actions of S100B, we
investigated the effect of adding exogenous S100B to our E13.5
gut explant cultures. Two different concentrations of S100B
were used, 5 and 500 nM (Cirillo et al., 2011), and added
either in combination with arundic acid, or alone. Therefore,
E13.5 Wnt1-CRE;R26R-GCaMP3 gut was cultured for 48 h
in six different culture conditions: in vehicle control, S100B
(5 nM), S100B (500 nM), arundic acid (300 µM) only, arundic
acid + S100B (5 nM), and arundic acid + S100B (500 nM).
Addition of either concentration of S100B alone did not
affect Sox10+ ENCCs compared to vehicle control (Figure 8).
Addition of S100B with arundic acid also did not change
Sox10+ ENCCs in comparison to culture in arundic acid alone
(Figure 8). This suggests that extracellular S100B does not
play a role at these early stages of ENS development, and that
the effects on Sox10 are mediated by cell-intrinsic sources of
S100B.
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FIGURE 8 | Addition of exogenous S100B did not rescue Sox10
expression. The density of Sox10+ ENCCs per 10000 µm2 of gut area was
not affected by the addition of either concentration of S100B alone.
Furthermore, addition of S100B with arundic acid did not change the density
of Sox10+ cells in comparison to culture in arundic acid alone. p > 0.05 for
all, one-way ANOVA, n-numbers shown (total number of Sox10+ cells:
control 554; S100B 5 nM 702; S100B 500 nM 574; arundic acid 248; arundic
acid + S100B 5 nM 266; arundic acid + S100B 500 nM 187).
DISCUSSION
Enteric glia are an integral part of the ENS and play many roles
in regulating neuronal function, as well as interacting with other
cell types in the gastrointestinal tract (Bush et al., 1998; Cornet
et al., 2001; Gomes et al., 2009; Gulbransen and Sharkey, 2009;
Kabouridis et al., 2015). S100B, Sox10 and GFAP are common
markers used to label glial cells in the mature ENS and it has
been found that the combination of expression of these markers
varies in different subtypes of enteric glia (Boesmans et al.,
2015b). Recently, proteolipid protein 1 (PLP1) has also been
shown to be expressed by enteric glia (Rao et al., 2015). In
this study, we show that S100B is important for enteric glial
differentiation. Using arundic acid to inhibit S100B synthesis, we
found that there were (i) decreased Sox10+ ENCC density and
Sox10 immunoreactivity; (ii) reduced ENCC proliferation; (iii)
co-localization of Sox10 and Hu in a small subpopulation of cells;
but (iv) no effect on the overall number of Hu+ enteric neurons.
A diagram of our proposed model is shown in Figure 9. It is our
hypothesis that by inhibiting S100B expression, glial precursors
fail to differentiate into enteric glia and a subpopulation begin
to differentiate into neurons (Figure 9). Our results suggest that
S100B could be important for maintaining Sox10 expression
during enteric gliogenesis.
Enteric Glia Differentiation
Glial differentiation in the ENS appears to lag behind enteric
neuron differentiation, as the first appearance of the “mature”
glial markers S100B and GFAP occur several days after the
first detection of pan-neuronal markers at E10.5 (Rothman
et al., 1986; Baetge and Gershon, 1989; Young et al., 2003). We
found that the proportion of S100B+ ENCCs increases gradually
during development, and similar to many other events in gut
development, the differentiation of glia also appears earlier in
the rostral small intestine compared to the colon. There are
four distinct subtypes of enteric glia in the mature gut (Hanani
and Reichenbach, 1994; Boesmans et al., 2015b), however, the
differentiation of these subtypes could not be determined in
our experiments as we were unable to examine individual cell
morphologies. However, at E16.5, S100B+ cells that were not
immunoreactive for Sox10 could mark the first appearance of
glia that express subtype-specific combinations of these markers.
Although GFAP and BFABP expression have been detected in
the embryonic gut in previous studies (Rothman et al., 1986;
Young et al., 2003), we were unable to label distinct cell bodies
for individual cell counting in this study.
Abolishing S100B in the ENS Using
Arundic Acid Decreases Sox10 Levels
and Reduces ENCC Proliferation
In the CNS, arundic acid has been shown to inhibit synthesis of
S100B reducing the levels of its mRNA and protein in astrocytes
(Tateishi et al., 2002; Asano et al., 2005). In our study, in
order to abolish S100B synthesis in developing glia, we added
arundic acid to embryonic gut from E13.5, the day before the
first immunohistochemical detection of S100B, in in vitro organ
culture. This culture system appears to have successfully inhibited
the onset of S100B production, as almost no, or very few, S100B-
immunoreactive cells could be detected in arundic acid, whilst
many S100B+ cells were present in control cultures.
Culture in arundic acid resulted in decreases in the density
of Sox10+ ENCCs, as well as reduced immunohistochemical
levels of Sox10 within cells. We also observed decreases in
the overall density of ENCCs and a decreased population of
proliferating ENCCs. It is well-known that Sox10 is important
for maintaining a “progenitor pool” in the ENS (Paratore
et al., 2001; Kim et al., 2003). Therefore, the reduction in
ENCC density and proliferation in our arundic acid cultures
could be due to the decrease in Sox10. Although some ENCCs
expressing pan-neuronal markers continue to proliferate during
ENS development (Young et al., 2005), because arundic acid did
not appear to influence enteric neuron numbers, it is unlikely that
their proliferation was affected.
Interestingly, the reduction in Sox10+ ENCCs and ENCC
proliferation was observed in both the duodenum and ileum
of arundic acid cultures, despite limited S100B-immunoreactive
glia in the ileum of control cultures. It is possible that low
levels of S100B protein are present in the ileum, but are below
immunohistochemical detection levels. It is also possible that
arundic acid acts via an S100B-independent mechanism, as in
addition to inhibition of S100B synthesis, arundic acid has also
been shown to influence the levels of several other proteins
(Asano et al., 2005). However, with the technical difficulties
posed by transfecting and transducing the ENS in intact gut
preparations (Boesmans et al., 2015a), we have not been able
to use a more specific, genetic approach for inhibiting S100B
expression and this pharmacological approach is currently our
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FIGURE 9 | Diagrammatic representation of the effects of arundic acid on ENS development. (A) During “normal” development, Sox10+ ENCC progenitor
cells divide and differentiation to produce neuronal and glial precursors (although the identity of the neuronal precursors remains to be examined). Glial precursors
and enteric glia remain proliferative, whilst there is limited proliferation of enteric neuronal precursors and neurons. S100B expression marks the differentiation of glial
precursors into glia, but how glial subtype differentiation occurs remains unknown. (B) Addition of arundic acid results in: (1) inhibition of S100B synthesis; (2) failure
of glial precursors to differentiate into S100B+ enteric glia and a severe reduction in the population of S100B+ enteric glia; (3) glial precursors that were committed
to turn on S100B expression exhibit decreases in their Sox10 protein levels; (4) and subsequently decrease in proliferation; (5) possible differentiation of some glial
precursors into neurons (or neuronal precursors) thereby producing Sox10+/Hu+ ENCCs; (6) cell death is also possible; (7) the longer term changes on enteric glial
differentiation remain to be examined further.
best method for reducing S100B synthesis in situ. In addition,
the results from our adult ENS cultures show that with the
presence of native S100B, arundic acid did not affect Sox10
levels. Therefore, while we cannot definitely show that S100B
influences Sox10 expression or protein levels, our results suggest
that the effects of arundic acid on Sox10 immunoreactivity were
dependent on S100B.
How the inhibition of S100B synthesis might reduce Sox10
levels is not known. S100B has many intracellular binding
partners (reviewed in Santamaria-Kisiel et al., 2006) and has been
shown to bind to the basic helix-loop-helix (bHLH) transcription
factor E12, also known as Tcf3, to inhibit its DNA binding
ability (Onions et al., 1997). Whether other similar transcription
factors might be affected remains to be investigated. Another
possible pathway is the binding of S100B to the tumor suppressor
protein, p53 (Baudier et al., 1992). This interaction reduces p53
activity and, therefore, increases cell proliferation (Lin et al., 2004,
2010). The role of p53 in cancer progression has been extensively
studied, but whether changes in p53 activity might be linked
with Sox10 expression during ENS development is unknown.
Recently, it has been shown that mice with neural crest specific
mutations in Geminin, which encodes a cell cycle dependent
protein, exhibit intestinal aganglionosis resulting from increased
p53-dependent apoptosis (Konstantinidou et al., 2016).
Although we saw very little cell death in our embryonic gut
cultures by TUNEL staining, we cannot exclude that death of
cells committed to glial differentiation contributes to the decrease
in Sox10+ and GFP+ numbers (Figure 9). Previous studies
have shown that ENCC cell death in the gut is difficult to
identify using conventional assays (Uesaka et al., 2007; Enomoto,
2009; Chalazonitis et al., 2012). Therefore, while the absence
of TUNEL+ cells may help confirm the lack of cytotoxicity of
arundic acid, it does not exclude the possibility of ENCC cell
death.
Addition of Exogenous Extracellular
S100B Does Not Rescue Sox10
Expression
Apart from its intracellular roles, extracellular S100B can also
influence many aspects of glial function (Donato et al., 2009).
Similar to the CNS, S100B in the gut has been postulated
to provide neurotrophic support at “lower” (nanomolar)
concentrations, whilst “higher” (micro-molar) concentrations of
S100B appear to lead to neuronal damage, such as during gut
inflammation (Cirillo et al., 2011). In our study, the addition of
exogenous extracellular S100B, at either concentration, had little
effect on ENCCs, and did not rescue the change in Sox10+ cell
numbers. Therefore, whilst released extracellular S100B can exert
influences on gene transcription in a paracrine (or autocrine)
fashion, we hypothesize that the effects of S100B on Sox10
observed in our study were due to its cell-intrinsic intracellular
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actions. The extracellular actions and appearance of receptors for
S100B could arise later in ENS development. It is also possible
that the S100B protein failed to penetrate the external serosal cell
layers in our embryonic gut explants, thereby, failing to contact
ENCCs. However, without a clear assay to examine the effect of
exogenous S100B application during embryonic development, it
is currently difficult to determine whether this lack of effect was
due to lack of penetration or because there are limited responses
to exogenous S100B.
Inhibition of S100B Synthesis Did Not
Affect Neuronal Differentiation
We did not observe any changes in the overall density of Hu+
enteric neurons in response to S100B cell loss. However, because
our embryonic gut cultures were only maintained for 48 h, we can
only conclude that the initiation of neuronal differentiation was
not influenced by the lack of S100B, which is in accordance with
the observation that neuronal differentiation generally precedes
glial differentiation. Interestingly, however, we did observe a
novel population of ENCCs that express both the neuronal
marker Hu and Sox10. Sox10 co-localization with neuronal
markers is rarely observed in the developing ENS (Young et al.,
2002; Anderson et al., 2006). A small population of Sox10+ cells
near the wavefront of ENCC migration that exhibit cytoplasmic
Hu immunoreactivity and weak PGP9.5 immunoreactivity are
thought to be progenitors that are beginning to acquire neuronal
phenotype (Young et al., 2004). In the adult ENS, cells that
exhibit both neuronal and glial markers can be identified, but
very rarely, and make up a very small proportion of the total
population of the ENS in the mouse (Musser et al., 2015). We
hypothesize that after culture in arundic acid, the Sox10 and
Hu co-expressing cells are glial progenitors that, due to the lack
of S100B expression and subsequent downregulation of Sox10,
are beginning to express pan-neuronal markers (Figure 9). It
is also possible that they are enteric neurons that up-regulate
Sox10; however, this would suggest a paracrine action of S100B,
which our results demonstrate to be unlikely at this stage of ENS
development. Future lineage tracing experiments are required to
determine the identity of these cells.
The effects of longer term reduction of S100B synthesis
remain to be investigated further. Continued inhibition of S100B
synthesis would eventually prevent paracrine (and autocrine)
S100B signaling and therefore, could influence later stages of
ENS development. However, in two independent lines of S100B
knockout mice, there appears to be little drastic effects on the
health of the animals (Xiong et al., 2000; Nishiyama et al.,
2002). Although changes were observed in various aspects of
their nervous system, the development of the cerebellum has
been examined in detail, and did not differ from wild type
littermates (Bluhm et al., 2015). However, the gut and ENS have
not been examined in these mice. It is possible that functional
redundancy or compensating mechanisms make up for the lack
of S100B during development, which could dilute the acute
effects observed in our cultures over time. Also, as S100B is not
expressed by all enteric glial populations (Boesmans et al., 2015b),
its effects on the development of different subtypes of enteric glia
remain to be investigated further.
CONCLUSION
In this study, we have been able to inhibit synthesis of S100B
using arundic acid in our embryonic gut culture system.
Preventing S100B synthesis led to a reduction in the number
of Sox10+ ENCCs, and decreases in the overall ENCC density
in the gut as well as reduced proliferation of ENCCs. Our
results suggest that S100B alters levels of Sox10 protein in
early differentiating glia, which is vital for maintaining their
proliferative potential. The long-term effects of this depletion on
later glial differentiation, enteric neuron density and function
require further investigation.
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